Missed the webinar on FDA-approved psychedelic clinical trials?
You can still catch the full discussion with Dr. Manish Agrawal, Sunstone’s CEO and Principal Investigator.
In this recorded session, Dr. Agrawal shares insights from Sunstone’s psychedelic therapy research, and reviews key considerations.
July 28, 2025 | Join us to explore the nuances of delivering psychedelic therapy within clinical trial protocols and clinical settings.
June 10, 2025 | An in person clinic visit to meet our clinical team, explore our ongoing clinical trials for complex mental health conditions, and learn more about the care we provide in our purpose built center for psychedelic-assisted therapy.
May 20, 2025 | This webinar explored the critical role of preparation visits in supporting patients through psychedelic therapy clinical trials.